Xinjiang Zhongtai Chemical Past Earnings Performance
Past criteria checks 0/6
Xinjiang Zhongtai Chemical's earnings have been declining at an average annual rate of -36%, while the Chemicals industry saw earnings growing at 8.4% annually. Revenues have been declining at an average rate of 15.7% per year.
Key information
-36.0%
Earnings growth rate
-35.5%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -15.7% |
| Return on equity | -10.6% |
| Net Margin | -8.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Xinjiang Zhongtai Chemical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 34,192 | -2,728 | 3,553 | 271 |
| 31 Dec 23 | 37,118 | -2,865 | 3,611 | 261 |
| 30 Sep 23 | 45,066 | -1,613 | 3,427 | 428 |
| 30 Jun 23 | 47,004 | -1,383 | 3,472 | 512 |
| 31 Mar 23 | 51,612 | -50 | 3,622 | 441 |
| 31 Dec 22 | 55,911 | 714 | 3,655 | 444 |
| 30 Sep 22 | 61,787 | 1,438 | 3,749 | 268 |
| 30 Jun 22 | 61,481 | 2,149 | 3,816 | 101 |
| 31 Mar 22 | 55,664 | 2,456 | 3,500 | 93 |
| 01 Jan 22 | 62,893 | 2,748 | 3,328 | 77 |
| 30 Sep 21 | 61,477 | 3,061 | 3,395 | 58 |
| 30 Jun 21 | 73,430 | 2,164 | 3,204 | 44 |
| 31 Mar 21 | 90,613 | 851 | 3,326 | 32 |
| 31 Dec 20 | 84,215 | 145 | 3,307 | 27 |
| 30 Sep 20 | 83,606 | -503 | 3,209 | 43 |
| 30 Jun 20 | 84,237 | -266 | 3,324 | 46 |
| 31 Mar 20 | 80,484 | 223 | 3,294 | 54 |
| 31 Dec 19 | 83,144 | 383 | 3,438 | 59 |
| 30 Sep 19 | 89,554 | 851 | 3,519 | 43 |
| 30 Jun 19 | 83,326 | 1,559 | 3,493 | 44 |
| 31 Mar 19 | 78,444 | 2,191 | 3,605 | 43 |
| 31 Dec 18 | 70,223 | 2,428 | 3,421 | 35 |
| 30 Sep 18 | 59,354 | 2,368 | 3,352 | 15 |
| 30 Jun 18 | 51,608 | 2,401 | 3,236 | 12 |
| 31 Mar 18 | 44,607 | 2,129 | 3,213 | 3 |
| 31 Dec 17 | 41,059 | 2,402 | 3,212 | 2 |
| 30 Sep 17 | 34,665 | 3,176 | 2,791 | 8 |
| 30 Jun 17 | 30,524 | 2,816 | 2,844 | 0 |
| 31 Mar 17 | 26,027 | 2,486 | 2,696 | 0 |
| 31 Dec 16 | 23,362 | 1,843 | 2,618 | 0 |
| 30 Sep 16 | 20,265 | 678 | 2,719 | 0 |
| 30 Jun 16 | 18,671 | 280 | 2,518 | 0 |
| 31 Mar 16 | 17,965 | 190 | 2,449 | 0 |
| 31 Dec 15 | 16,471 | 30 | 2,365 | 0 |
| 30 Sep 15 | 14,801 | 146 | 2,227 | 0 |
| 30 Jun 15 | 13,282 | 175 | 2,123 | 0 |
| 31 Mar 15 | 11,421 | 132 | 1,967 | 0 |
| 31 Dec 14 | 11,177 | 332 | 1,845 | 0 |
| 30 Sep 14 | 11,319 | 250 | 1,804 | 0 |
| 30 Jun 14 | 11,629 | 263 | 1,751 | 0 |
| 31 Mar 14 | 11,597 | 137 | 1,716 | 0 |
| 31 Dec 13 | 12,046 | 114 | 1,716 | 0 |
| 30 Sep 13 | 10,743 | 238 | 1,535 | 0 |
| 30 Jun 13 | 9,363 | 215 | 1,317 | 0 |
Quality Earnings: 002092 is currently unprofitable.
Growing Profit Margin: 002092 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002092 is unprofitable, and losses have increased over the past 5 years at a rate of 36% per year.
Accelerating Growth: Unable to compare 002092's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002092 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-21.2%).
Return on Equity
High ROE: 002092 has a negative Return on Equity (-10.63%), as it is currently unprofitable.